Satellite Banner
Technology Networks Header
Thursday, October 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
New Mass Spectral Library Designed to Streamline Environmental, Food Safety, Clinical Research and Forensic Toxicology Analyses
Monday, June 16, 2014
Laboratories analyzing environmental, clinical research/toxicological and food samples have a powerful new data tool expected to save time and money while identifying compounds with high levels of confidence.

New Mass Spectrometric Immunoassay Consumables Enable Large Biomolecule Analysis
Monday, June 16, 2014
The new functionalized pipette tips feature proprietary microcolumn technology designed to enable enhanced, reproducible target purification and reduce complexity in biological samples prior to liquid chromatography-mass spectrometry (LC-MS) protocols.

Bruker Announces Powerful New Mass Spectrometry Systems and Solutions
Monday, June 16, 2014
The products for life-science research, clinical research, biopharma and applied markets were announced at the 62nd ASMS Conference on MS.

Shimadzu’s New GCMS-TQ8040 with Smart MRM Transforms Analysis by Triple Quadrupole GC-MS/MS
Monday, June 16, 2014
Smart Productivity, Smart Operation and Smart Performance: Smart enough for everyday laboratory use!

Noviplex™ Card Plasma Separator Technology Simplifies Plasma Sampling for MS-based Research
Monday, June 16, 2014
Noviplex Cards allow for rapid collection of a volumetric sample of plasma from an unmeasured amount of whole blood within minutes.

Shimadzu Releases QuantAnalyticsTM Open Access LCMS Software Package for Clinical Applications
Monday, June 16, 2014
The software increases the speed and efficiency of data processing and review by allowing users to highlight and review results that are of specific importance to clinicians.

AB SCIEX Launches Innovative Solutions for Therapeutics Development and Analysis
Monday, June 16, 2014
Three New Tools Accelerate the Study of Intact Proteins and Peptide Mapping: BioPharmaView™ Software, the TripleTOF® 6600 System, and SWATH™ Acquisition 2.0.

AB SCIEX Next-Generation Proteomics Platform Transforms Proteomics Research
Monday, June 16, 2014
New TripleTOF® 6600 System with SWATH™ Acquisition 2.0 captures every detectable protein and peptide in every run for deep hnsights into the proteome.

Waters Progenesis QI for Proteomics Version 2.0 Unveiled at ASMS with New Features
Monday, June 16, 2014
Advanced LC-MS 'Omics analysis software for proteomics applications is more rapid and reliable than ever.

<< 2 3 4 5 6 7 8 >>
Showing Results 41 - 50 of 1105
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv